Long ‐term clinical and haemodynamic results after transcatheter annuloplasty for secondary mitral regurgitation

ConclusionsAmong high ‐risk patients undergoing transcatheter mitral valve annuloplasty for symptomatic secondary MR, mortality was ~50% at 4 years. In the surviving patients, reduced MR severity was associated with reduced NYHA functional class, reverse LV remodelling, and improved LV function.

Source: ESC Heart Failure - May 3, 2021 Category: Cardiology Authors: Daniel Lavall, Julius Bruns, Tina Stegmann, Andreas Hagendorff, Stephan St öbe, Ulrich Laufs Tags: Original Research Article Source Type: research